The Hot Tort Report:
November 2024
The Hottest in Mass Tort Spending: October 2024
Featured Tort
Birth Control Injections
Subscribe to the Hot Tort Report
What’s the Tort News?
Published: November, 2024. TV spend from multiple sources for a recent 30 day period.
If you have any questions, please contact Bails at bails@whitehardt.com
#1 Mesothelioma – $1,445,000
October TV ad spending for the Mesothelioma mass tort has dropped to its lowest level in 2024, though it remains substantial. A recent $15 million verdict against Johnson & Johnson in Connecticut reinforces the high stakes in this ongoing litigation. For law firms invested in Mesothelioma cases, Whitehardt can support your firm in maximizing reach within this competitive field.
For metrics such as CPA, CPL, and criteria, please contact us.
#2 Takata Airbag Recall – $100,000
The Takata Airbag Recall mass tort is back on the rise, with an increase of about $15,000 over last month. However, it still hasn’t reached the higher levels seen in July and August. While settlements are now available within class actions, there remains significant potential in individual personal injury cases yet to be filed. Whitehardt can help your firm effectively reach potential claimants as this mass tort gains renewed momentum.
For metrics such as CPA, CPL, and criteria, please contact us.
#3 Birth Control Injections – $35,000
After entering our list last month, TV ad spending for the Birth Control Injections mass tort continues to climb as the first lawsuit, filed on behalf of Kristina Schmidt, gains attention. Concerns are mounting over the lack of a meningioma warning on U.S. labels, despite its inclusion on European labels. With this litigation still in its early stages, now is the time for law firms to establish their presence. Whitehardt can assist in crafting an effective outreach strategy as this case unfolds.
For metrics such as CPA, CPL, and criteria, please contact us.
#4 Birth Injury – $33,000
Making a strong return since its last appearance in April, the Birth Injury mass tort reached its highest TV ad spending in months, even surpassing the recently popular NEC Infant Formula tort. This increased focus highlights the ongoing importance of birth injury litigation as parents seek justice for children impacted by medical negligence. Unlike many torts tied to specific companies, events, or discontinued products, birth injury risks are ever-present, making this a consistently relevant area for legal advocacy.
For metrics such as CPA, CPL, and criteria, please contact us.
#5 Infant Formula – $22,000
TV ad spending for the NEC Infant Formula mass tort has dropped significantly, falling to less than 3% of last month’s total, which had held the #2 position. This decline follows a Missouri judge’s recent ruling that barred formula makers from using a U.S. government statement suggesting no conclusive link to NEC in premature infants as part of their defense. Despite this decrease in TV ad spending, the litigation remains active and this development is a positive for plaintiffs.
Common Criteria: Premature child born after 2002, severe injuries related to diagnosis of NEC, was fed formula in hospital. Infant was fed cow-milk-based formula (okay if unsure of brand) AND was diagnosed with NEC in or after the year 2002. If not premature, infant was diagnosed with NEC within 3 months after birth AND had surgery.
For metrics such as CPA and CPL, please contact us.
#6 Paraquat – $16,000
The Paraquat mass tort’s TV ad spend has dropped again, now at less than half of last month’s total and marking the second-lowest point this year. Given the volatility of spending in recent months, it wouldn’t be surprising to see renewed interest in this litigation soon. For law firms navigating this unpredictable landscape, Whitehardt can help adjust your strategy to capture opportunities if interest resurges.
CPL: $1,200
CPA: $2,667
Common Criteria: Diagnosis of Parkinson’s Disease or experiencing Parkinson’s-like symptoms after exposure to Paraquat.
#7 AFFF – $14,000
Last seen on June’s Hot Tort Report, the AFFF mass tort returns with renewed attention following Carrier Global’s $730 million settlement over PFAS-related claims tied to its fire protection products. As awareness of PFAS chemicals, also known as “forever chemicals,” continues to grow, this litigation is expected to develop further.
CPL: $1,750
CPA: $3,500
For criteria, please contact us.
#8 9/11 Claims – $13,000
Reappearing after several months of little to no TV ad spending, the 9/11 Claims mass tort has seen a recent increase in activity. This renewed spending reflects ongoing efforts to connect with those affected by the long-term health impacts of 9/11 exposures.
For metrics such as CPA, CPL, and criteria, please contact us.
#9 Hernia Mesh – $12,000
This tort’s TV spend has dropped to about 10% of last month’s level following Becton Dickinson’s settlement of the majority of lawsuits. Covering thousands of cases, this agreement aims to provide relief for patients who allege harm from Bard and Davol hernia mesh products, though the company has not admitted any wrongdoing. Whitehardt can assist firms in strategically reaching out to claimants as settlement payouts are distributed over the coming years.
Common Criteria: Hernia mesh surgery from 2000—current and suffered from one of the following: Perforation, Bowel Obstruction, Mesh Erosion, Mesh Contraction, Torn Mesh, Sepsis/Infection, Granuloma, Adhesion, Dehiscence that resulted in a removal/repair, scheduled or future.
For metrics such as CPA and CPL, please contact us.
